Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ovarian Cancer Research Alliance (OCRA) is the largest global non-profit organization dedicated to advancing ovarian cancer research, advocacy, and patient support. Formed by the 2016 merger of the Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA), the organization has invested over $110 million in scientific research to improve treatments and find a cure. OCRA's mission encompasses funding high-impact research, advocating for increased federal funding on Capitol Hill, and providing comprehensive support programs for survivors and their families. Their initiatives include the "Woman to Woman" peer support program and the "Survivors Teaching Students" educational program for medical professionals, which helps future doctors understand the patient experience and early symptoms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ovarian Cancer Survivor Network.